Renaissance Technologies
FLGT icon

Renaissance Technologies’s Fulgent Genetics FLGT Stock Holding History

Renaissance Technologies’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$286K Sell
18,000
-64,864
-78% -$1.41M ﹤0.01% 2804
2025
Q4 		$2.18M Buy
+82,864
New +$2.15M ﹤0.01% 1810
2025
Q2 		– Sell
-10,400
Closed -$176K – 3652
2025
Q1 		$176K Sell
10,400
-14,500
-58% -$247K ﹤0.01% 3103
2024
Q4 		$460K Sell
24,900
-8,100
-25% -$158K ﹤0.01% 2876
2024
Q3 		$717K Sell
33,000
-10,900
-25% -$244K ﹤0.01% 2619
2024
Q2 		$861K Sell
43,900
-1,600
-4% -$33.4K ﹤0.01% 2405
2024
Q1 		$987K Sell
45,500
-1,800
-4% -$44.7K ﹤0.01% 2493
2023
Q4 		$1.37M Sell
47,300
-17,400
-27% -$466K ﹤0.01% 2202
2023
Q3 		$1.73M Sell
64,700
-32,254
-33% -$1.1M ﹤0.01% 1949
2023
Q2 		$3.59M Buy
96,954
+14,000
+17% +$488K 0.01% 1613
2023
Q1 		$2.59M Buy
82,954
+12,554
+18% +$404K ﹤0.01% 1865
2022
Q4 		$2.1M Sell
70,400
-99,200
-58% -$3.55M ﹤0.01% 2036
2022
Q3 		$6.46M Sell
169,600
-7,900
-4% -$396K 0.01% 1292
2022
Q2 		$9.68M Buy
177,500
+74,600
+72% +$4.1M 0.01% 1133
2022
Q1 		$6.42M Buy
102,900
+96,600
+1,533% +$6.36M 0.01% 1413
2021
Q4 		$634K Buy
+6,300
New +$554K ﹤0.01% 2967
2020
Q2 		– Sell
-11,521
Closed -$124K – 3551
2020
Q1 		$124K Sell
11,521
-76,900
-87% -$1.07M ﹤0.01% 3188
2019
Q4 		$1.14M Sell
88,421
-82,059
-48% -$975K ﹤0.01% 2568
2019
Q3 		$1.77M Buy
170,480
+138,414
+432% +$1.31M ﹤0.01% 2344
2019
Q2 		$214K Buy
32,066
+5,966
+23% +$36.3K ﹤0.01% 3285
2019
Q1 		$155K Buy
+26,100
New +$120K ﹤0.01% 3242

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies's FLGT Position: Q1 2026 in Review

Renaissance Technologies reduced its Fulgent Genetics (FLGT) stake by 78% in Q1 2026, selling an estimated $1.41M and leaving 18,000 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #2804.

Renaissance Technologies first reported a position in FLGT in Q1 2019 and has held it in 21 quarters since. The position peaked at $9.68M in Q2 2022. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Renaissance Technologies held 18,000 shares of Fulgent Genetics worth $286K as of Q1 2026.
  • Renaissance Technologies sold 64,864 Fulgent Genetics shares in Q1 2026, an estimated $1.41M.
  • Fulgent Genetics made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2804 holding.
  • Renaissance Technologies first reported a position in Fulgent Genetics in Q1 2019 and has held it in 21 quarters since.
  • Renaissance Technologies's Fulgent Genetics position peaked at $9.68M in Q2 2022.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.